Skip to main content

Table 2 Eligibility and Evaluability of Non-Fatal and Fatal Cases

From: Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children

  NPDS (n%) FAERS (n%) MFR (n%) ML (n%) News/Media (n%) Multiple Sourcea (n%) Total (n%)
Non-Fatal Unique Eligible Cases (n) 6094 272 497 78 10 61 7,012
Unevaluable (Unable to Determine Relatedness) 518 (8.5%) 27 (9.9%) 99 (19.9%) 7 (9.0%) 6 (60.0%) 13 (21.3%) 670 (9.6%)
Evaluable 5576 (91.5%) 245 (90.1%) 398 (80.1%) 71 (91.0%) 4 (40.0%) 48 (78.7%) 6342 (90.4%)
At Least Potentially Related 5345 (95.9%) 55 (22.4%) 204 (51.3%) 18 (25.4%) 2 (50.0%) 22 (45.8%) 5646 (89.0%)
Unlikely Related 231 (4.1%) 190 (77.6%) 194 (48.7%) 53 (74.6%) 2 (50.0%) 26 (54.2%) 696 (11.0%)
Fatal Unique Eligible Cases (n) 19 19 52 6 32 44 172
 Unevaluable (Unable to Determine Relatedness) 8 (42.1%) 5 (26.3%) 25 (48.1%) 2 (33.3%) 12 (37.5%) 15 (34.1%) 67 (39.0%)
Evaluable 11 (57.9%) 14 (73.7%) 27 (51.9%) 4 (66.7%) 20 (62.5%) 29 (65.9%) 105 (61.0%)
At Least Potentially Related 7 (63.6%) 7 (50.0%) 19 (70.4%) 2 (50.0%) 17 (85.0%) 24 (82.8%) 76 (72.4%)
Unlikely Related 4 (36.4%) 7 (50.0%) 8 (29.6%) 2 (50.0%) 3 (15.0%) 5 (17.2%) 29 (27.6%)
  1. aCase reports from more than one data source are combined to a unique case and are designated as Multiple Source